| Baldemar Covarrubias Jr, MD | |
|
5718 Spohn Dr, Suite 100, Corpus Christi, TX 78414-4235 | |
| (361) 980-0808 | |
| (361) 980-0088 |
| Full Name | Baldemar Covarrubias Jr |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 37 Years |
| Location | 5718 Spohn Dr, Corpus Christi, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033191135 | NPI | - | NPPES |
| 136778106 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | H4253 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mi Familia Home Health | Alice, TX | Home health agency |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baldemar Covarrubias M.d., Pa | 1759397854 | 5 |
News Archive
ExeVir, which is developing single domain antibody therapies providing broad protection against viral infections, today announces that the first subjects have been dosed in a Phase I clinical study of XVR011, its llama-derived antibody for the treatment and prevention of COVID-19.
Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for the orphan drug VALCHLOR (mechlorethamine) gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.
In a review article publishing this week in JAMA Internal Medicine, physicians at Johns Hopkins, along with experts from several other institutions across north America, compiled published evidence and crafted an experience-based quality improvement blueprint to reduce repetitive lab testing for hospitalized patients.
Knowledge about the vitamin D level of a population is important in order to assess the proportion that is vitamin D deficient or is at risk of becoming deficient, and to develop food strategies that will ensure optimal vitamin D intake. By using a standardizing method it is possible to compare existing vitamin D measurements across studies and countries.
› Verified 3 days ago
| Entity Name | Baldemar Covarrubias M.d., Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689697096 PECOS PAC ID: 1759397854 Enrollment ID: O20060227000680 |
News Archive
ExeVir, which is developing single domain antibody therapies providing broad protection against viral infections, today announces that the first subjects have been dosed in a Phase I clinical study of XVR011, its llama-derived antibody for the treatment and prevention of COVID-19.
Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for the orphan drug VALCHLOR (mechlorethamine) gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.
In a review article publishing this week in JAMA Internal Medicine, physicians at Johns Hopkins, along with experts from several other institutions across north America, compiled published evidence and crafted an experience-based quality improvement blueprint to reduce repetitive lab testing for hospitalized patients.
Knowledge about the vitamin D level of a population is important in order to assess the proportion that is vitamin D deficient or is at risk of becoming deficient, and to develop food strategies that will ensure optimal vitamin D intake. By using a standardizing method it is possible to compare existing vitamin D measurements across studies and countries.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Baldemar Covarrubias Jr, MD 5718 Spohn Dr, Suite 100, Corpus Christi, TX 78414-4235 Ph: (361) 980-0808 | Baldemar Covarrubias Jr, MD 5718 Spohn Dr, Suite 100, Corpus Christi, TX 78414-4235 Ph: (361) 980-0808 |
News Archive
ExeVir, which is developing single domain antibody therapies providing broad protection against viral infections, today announces that the first subjects have been dosed in a Phase I clinical study of XVR011, its llama-derived antibody for the treatment and prevention of COVID-19.
Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for the orphan drug VALCHLOR (mechlorethamine) gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.
In a review article publishing this week in JAMA Internal Medicine, physicians at Johns Hopkins, along with experts from several other institutions across north America, compiled published evidence and crafted an experience-based quality improvement blueprint to reduce repetitive lab testing for hospitalized patients.
Knowledge about the vitamin D level of a population is important in order to assess the proportion that is vitamin D deficient or is at risk of becoming deficient, and to develop food strategies that will ensure optimal vitamin D intake. By using a standardizing method it is possible to compare existing vitamin D measurements across studies and countries.
› Verified 3 days ago
Dr. Dimple Butler, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5950 Saratoga Blvd, Corpus Christi, TX 78414 Phone: 361-881-3410 | |
Patrick B. Higdon, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 805 Morgan Ave, Corpus Christi, TX 78404 Phone: 210-762-3662 Fax: 361-730-2172 | |
Ruben J Almanza, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5446 Lipes Blvd Ste 101, Corpus Christi, TX 78413 Phone: 361-992-6100 Fax: 361-992-0665 | |
Dr. Brenda S Gardner, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 5283 Old Brownsville Rd, ., Corpus Christi, TX 78405 Phone: 361-806-5600 Fax: 361-806-5601 | |
Dr. Patricia Ann Cantu, MD PA Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 Texan Trl Ste 200, Corpus Christi, TX 78411 Phone: 361-986-9300 Fax: 361-986-9301 | |
Danielle Lovett Mccandless, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3315 S Alameda St, Corpus Christi, TX 78411 Phone: 361-882-3198 Fax: 361-884-1912 | |
Medha Chunduru, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1521 S Staples St Ste 300, Corpus Christi, TX 78404 Phone: 361-694-1498 Fax: 361-694-1499 |